Prevalence of Chagas disease in blood donors at the Uberaba Regional Blood Center, Brazil, from 1995 to 2009

被引:13
作者
de Lima, Laryssa Manso [1 ]
Alves, Nathalia Passos [2 ]
Barbosa, Valdirene de Fatima [3 ]
Pimenta, Gustavo Alves [4 ]
Moraes-Souza, Helio [5 ]
Juliano Martins, Paulo Roberto [5 ]
机构
[1] Univ Fed Triangulo Mineiro, Curso Med, Uberaba, MG, Brazil
[2] Univ Uberaba, Curso Med, Uberaba, MG, Brazil
[3] Grp Pesquisa Seguranca Transfus CNPq UFTM, Uberaba, MG, Brazil
[4] Univ Fed Triangulo Mineiro, Disciplina Bioestat, Uberaba, MG, Brazil
[5] Univ Fed Triangulo Mineiro, Disciplina Hematol & Hemoterapia, Uberaba, MG, Brazil
关键词
Chagas disease; Transmission by transfusion; Blood donors; Serologic ineligibility; TRANSFUSIONAL TRANSMISSION; TRYPANOSOMA-CRUZI; COUNTRIES;
D O I
10.1590/S0037-86822012000600013
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: A retrospective study was conducted to assess the occurrence of blood donations that were ineligible due to Chagas disease infection from 1995 to 2009 at the Uberaba Regional Blood Center (HRU), Brazil, verify the tendency of this ineligibility, and describe the epidemiologic profile of the donors. Methods: Retrospective studies of serological ineligibility due to Chagas disease, statistical analysis by means of the chi-square test and odds ratio, study of the tendencies using a dispersion graph and the linear correlation coefficient (r) were performed. Results: In the period under study, a 0.2% serum prevalence of ineligibility due to Chagas disease was found, with a significant drop in ineligible donations from 2001 to 2009. Among the serum positive-donors, there was a significant predominance among those aged 30 years or above and non-single individuals. Conclusions: The results show a rate of occurrence that is lower than that described in literature, as well as a progressive drop during the 15 years under assessment. Such results are a consequence of systematic combat of the vector since the 70s and the progressive and consistent increase of returning donors, resulting in a drop of the contamination risk factor by means of blood transfusion and in the improvement of the quality of hemotherapy practices in the HRU.
引用
收藏
页码:723 / 726
页数:4
相关论文
共 19 条
  • [1] Agencia Nacional de Vigilancia Sanitaria (ANVISA), 1993, PORT 1 376
  • [2] [Anonymous], 2016, TRANSFUS MED HEMOTH, DOI DOI 10.1159/000446218
  • [3] Blood Products Advisory Committee, 2002, BLOOD PROD ADV COMM
  • [4] Callegari-Jaques S., 2003, Bioestatistica: Principios e Aplicacoes
  • [5] Fitarelli Douglas B., 2009, Rev. Bras. Hematol. Hemoter., V31, P310
  • [6] Fundacao Oswaldo Cruz (FIOCRUZ), DOENC CHAG WEB SIT
  • [7] LANA M., 2005, PARASITOLOGIA HUMANA, P85
  • [8] Trypanosoma cruzi in a low- to moderate-risk blood donor population:: seroprevalence and possible congenital transmission
    Leiby, DA
    Fucci, MH
    Stumpf, RJ
    [J]. TRANSFUSION, 1999, 39 (03) : 310 - 315
  • [9] Lunardelli A, 2007, REV BRAS ANAL CLIN, V39, P139
  • [10] Mazza S., 1936, MEPRA, V28, P41